Mebikar - instructions for use, dose, side effects, contraindications

Similar drugsTo uncover

Dosage form: & nbsppills

Composition:

active substance - mebicar 0.3 g;

auxiliary substances: povidong (polyvinylpyrrole idonco-molecular) 0.0015 g, calcium stearate 0.0015 g.

Description:tablets of white color, flat-cylindrical with a facet and a risk.

Pharmacotherapeutic group:anxiolytic (tranquilizer).

Pharmacodynamics:

The drug refers to anxiolytic, stress-protective, nootropic drugs. Improves the oxygen supply of myocardial tissue; normalizes the disturbed electrolyte balance of blood, the content of potassium ions in plasma, erythrocytes and myocardial cells; promotes the enhancement of protein synthesis and the increase in energy resources of the cell.

Regulates disturbed sleep at night, without direct sedative action. Has no cholinolytic and muscle relaxant effect, does not disrupt the coordination of movements. Relieves or removes nicotine withdrawal.

Pharmacokinetics:It is excreted completely in the urine within 24 hours.

Indications:

for the treatment of neurotic disorders (irritability, emotional lability, anxiety, anxiety-depressive, phobic, panic disorders) that developed as a result of exhausting psycho-emotional, neuropsychic and physical exertion.In complex therapy for the treatment of patients with cardialgia, ischemic heart disease and rehabilitation after myocardial infarction.

To reduce the craving for tobacco smoking; with neurosis-like conditions in patients with alcoholism, to reduce the pathological attraction to alcohol and psychoactive substances; to improve the tolerability of neuroleptics and tranquilizers.

Contraindications:Hypersensitivity.

Dosing and Administration:

Inside, 0.3-0.9 g 2-3 times a day (regardless of food intake). The maximum single dose - 3 grams, daily - 10 g. The course for prevention and treatment from several days to 2-3 months, depending on the situation, with mental illness up to 6 months.

Side effects:

Allergic reactions (skin itching), at high doses - a short-term insignificant decrease in blood pressure, hyperthermia (an increase in body temperature by 1-1.5 ° C), dyspeptic disorders. Reduction of blood pressure and body temperature are not indications for drug withdrawal and normalize on their own.

Interaction:Strengthens the effect of sleeping pills and narcotic drugs.

Form release / dosage:

Tablets 0.3 g.

Packaging:10 tablets per contour cell pack. 1 or 2 contour packagings along with the instructions for use are placed in packs.

Storage conditions:

List B. In a dry place. Keep out of the reach of children.

Shelf life:4 years. Do not use after the expiry date printed on the package.

Terms of leave from pharmacies:On prescription

Registration number:LSR-001481/08

Date of registration:14.03.2008

The owner of the registration certificate:TATHIMFARMPREPARATY, JSC TATHIMFARMPREPARATY, JSC Russia

Manufacturer: & nbsp

TATHIMFARMPREPARATY, JSC Russia

Information update date: & nbsp26.09.2015

Illustrated instructions

Instructions

Mebikar (Mebicar)